Compare Mutual Funds
Tata Nifty MidSmall Healthcare Index Fund
EquitySectoral-Pharma
Select a Mutual Fund
Risk
Very High
-
Rating
-
-
Min SIP Amount
₹100
-
Expense Ratio
1.14
-
NAV
₹14.47
-
Fund Started
08 Apr 2024
-
Fund Size
₹220.69 Cr
-
Exit Load
Exit load of 0.25%, if redeemed within 15 days.
-
1 Year
10.32%
-
3 Year
-
-
5 Year
-
-
Equity
100.14%
-
Cash
-0.14%
-
Top 10 Holdings
Name | Assets |
|---|---|
Laurus Labs Ltd. | 11.84% |
Lupin Ltd. | 7.57% |
Aurobindo Pharma Ltd. | 7.09% |
Fortis Healthcare Ltd. | 6.16% |
Glenmark Pharmaceuticals Ltd. | 5.40% |
Alkem Laboratories Ltd. | 4.78% |
Mankind Pharma Ltd. | 4.36% |
Ipca Laboratories Ltd. | 4.11% |
Biocon Ltd. | 3.96% |
Gland Pharma Ltd. | 3.55% |
-
Name
-
-
Start Date
-
-
Description
The scheme seeks to provide returns, before expenses, that are in line with the performance of Nifty MidSmall Healthcare Index (TRI), subject to tracking error.
-
Launch Date
08 Apr 2024
-
